# Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer

> **NCT02410369** · PHASE2 · UNKNOWN · sponsor: **Tokyo University** · enrollment: 60 (estimated)

## Conditions studied

- Non-small- Cell Lung Cancer

## Interventions

- **DRUG:** S-588410
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02410369
- **Lead sponsor:** Tokyo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2020-03
- **Final completion:** 2021-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02410369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02410369, "Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02410369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*